Epigenetics of cognition and behavior: insights from Mendelian disorders of epigenetic machinery

go back to reference Waddington CH. The epigenotype. Endeavour. 1942;1:18–20. Waddington CH. The epigenotype. Endeavour. 1942;1:18–20.

go back to reference Gibney ER, Nolan CM. Epigenetics and gene expression. Heredity. 2010;105(1):4–13.PubMedCrossRef Gibney ER, Nolan CM. Epigenetics and gene expression. Heredity. 2010;105(1):4–13.PubMedCrossRef

go back to reference Iwase S, Bérubé NG, Zhou Z, Kasri NN, Battaglioli E, Scandaglia M, Barco A. Epigenetic etiology of intellectual disability. J Neurosci. 2017;37(45):10773–82.PubMedPubMedCentralCrossRef Iwase S, Bérubé NG, Zhou Z, Kasri NN, Battaglioli E, Scandaglia M, Barco A. Epigenetic etiology of intellectual disability. J Neurosci. 2017;37(45):10773–82.PubMedPubMedCentralCrossRef

go back to reference Parenti I, Rabaneda LG, Schoen H, Novarino G. Neurodevelopmental disorders: from genetics to functional pathways. Trends Neurosci. 2020;43(8):608–21.PubMedCrossRef Parenti I, Rabaneda LG, Schoen H, Novarino G. Neurodevelopmental disorders: from genetics to functional pathways. Trends Neurosci. 2020;43(8):608–21.PubMedCrossRef

go back to reference Salinas RD, Connolly DR, Song H. Invited review: epigenetics in neurodevelopment. Neuropathol Appl Neurobiol. 2020;46(1):6–27.PubMedPubMedCentralCrossRef Salinas RD, Connolly DR, Song H. Invited review: epigenetics in neurodevelopment. Neuropathol Appl Neurobiol. 2020;46(1):6–27.PubMedPubMedCentralCrossRef

go back to reference Jang HS, Shin WJ, Lee JE, Do JT. CpG and non-CpG methylation in epigenetic gene regulation and brain function. Genes. 2017;8(6):148.PubMedPubMedCentralCrossRef Jang HS, Shin WJ, Lee JE, Do JT. CpG and non-CpG methylation in epigenetic gene regulation and brain function. Genes. 2017;8(6):148.PubMedPubMedCentralCrossRef

go back to reference Ladd-Acosta C, Pevsner J, Sabunciyan S, Yolken RH, Webster MJ, Dinkins T, Callinan PA, Fan J, Potash JB, Feinberg AP. DNA methylation signatures within the human brain. Am J Hum Genet. 2007;81(6):1304–15.PubMedPubMedCentralCrossRef Ladd-Acosta C, Pevsner J, Sabunciyan S, Yolken RH, Webster MJ, Dinkins T, Callinan PA, Fan J, Potash JB, Feinberg AP. DNA methylation signatures within the human brain. Am J Hum Genet. 2007;81(6):1304–15.PubMedPubMedCentralCrossRef

go back to reference Lister R, Mukamel EA, Nery JR, Urich M, Puddifoot CA, Johnson ND, Lucero J, Huang Y, Dwork AJ, Schultz MD, Yu M, Tonti-Filippini J, Heyn H, Hu S, Wu JC, Rao A, Esteller M, He C, Haghighi FG, Sejnowski TJ, Behrens MM, Ecker JR. Global epigenomic reconfiguration during mammalian brain development. Science. 2013;341(6146):1237905.PubMedPubMedCentralCrossRef Lister R, Mukamel EA, Nery JR, Urich M, Puddifoot CA, Johnson ND, Lucero J, Huang Y, Dwork AJ, Schultz MD, Yu M, Tonti-Filippini J, Heyn H, Hu S, Wu JC, Rao A, Esteller M, He C, Haghighi FG, Sejnowski TJ, Behrens MM, Ecker JR. Global epigenomic reconfiguration during mammalian brain development. Science. 2013;341(6146):1237905.PubMedPubMedCentralCrossRef

go back to reference Juriaans AF, Kerkhof GF, Mahabier EF, Sas TCJ, Zwaveling-Soonawala N, Touwslager RNH, Rotteveel J, Hokken-Koelega ACS. Temple syndrome: clinical findings, body composition and cognition in 15 patients. Clin Chem (Baltimore, Md). 2022;11(21):6289. Juriaans AF, Kerkhof GF, Mahabier EF, Sas TCJ, Zwaveling-Soonawala N, Touwslager RNH, Rotteveel J, Hokken-Koelega ACS. Temple syndrome: clinical findings, body composition and cognition in 15 patients. Clin Chem (Baltimore, Md). 2022;11(21):6289.

go back to reference Heald M, Adams D, Walls E, Oliver C. Refining the behavioral phenotype of Angelman syndrome: examining differences in motivation for social contact between genetic subgroups. Front Behav Neurosci. 2021;15: 618271.PubMedPubMedCentralCrossRef Heald M, Adams D, Walls E, Oliver C. Refining the behavioral phenotype of Angelman syndrome: examining differences in motivation for social contact between genetic subgroups. Front Behav Neurosci. 2021;15: 618271.PubMedPubMedCentralCrossRef

go back to reference Baker EK, Butler MG, Hartin SN, Ling L, Bui M, Francis D, Rogers C, Field MJ, Slee J, Gamage D, Amor DJ, Godler DE. Relationships between UBE3A and SNORD116 expression and features of autism in chromosome 15 imprinting disorders. Transl Psychiatry. 2020;10(1):362.PubMedPubMedCentralCrossRef Baker EK, Butler MG, Hartin SN, Ling L, Bui M, Francis D, Rogers C, Field MJ, Slee J, Gamage D, Amor DJ, Godler DE. Relationships between UBE3A and SNORD116 expression and features of autism in chromosome 15 imprinting disorders. Transl Psychiatry. 2020;10(1):362.PubMedPubMedCentralCrossRef

go back to reference Kishi Y, Fujii Y, Hirabayashi Y, Gotoh Y. HMGA regulates the global chromatin state and neurogenic potential in neocortical precursor cells. Nat Neurosci. 2012;15(8):1127–33.PubMedCrossRef Kishi Y, Fujii Y, Hirabayashi Y, Gotoh Y. HMGA regulates the global chromatin state and neurogenic potential in neocortical precursor cells. Nat Neurosci. 2012;15(8):1127–33.PubMedCrossRef

go back to reference Meshorer E, Yellajoshula D, George E, Scambler P, Brown D, Misteli T. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell. 2012;22(1):233–4.CrossRef Meshorer E, Yellajoshula D, George E, Scambler P, Brown D, Misteli T. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell. 2012;22(1):233–4.CrossRef

go back to reference Kim YJ, Khoshkhoo S, Frankowski JC, Zhu B, Abbasi S, Lee S, Wu YE, Hunt RF. Chd2 is necessary for neural circuit development and long-term memory. Neuron. 2018;100(5):1180-1193.e6.PubMedPubMedCentralCrossRef Kim YJ, Khoshkhoo S, Frankowski JC, Zhu B, Abbasi S, Lee S, Wu YE, Hunt RF. Chd2 is necessary for neural circuit development and long-term memory. Neuron. 2018;100(5):1180-1193.e6.PubMedPubMedCentralCrossRef

go back to reference Watson LA, Wang X, Elbert A, Kernohan KD, Galjart N, Berube NG. dual effect of CTCF loss on neuroprogenitor differentiation and survival. J Neurosci. 2014;34(8):2860–70.PubMedPubMedCentralCrossRef Watson LA, Wang X, Elbert A, Kernohan KD, Galjart N, Berube NG. dual effect of CTCF loss on neuroprogenitor differentiation and survival. J Neurosci. 2014;34(8):2860–70.PubMedPubMedCentralCrossRef

go back to reference Mossink B, Negwer M, Schubert D, Nadif Kasri N. The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective. Cell Mol Life Sci. 2021;78(6):2517–63.PubMedCrossRef Mossink B, Negwer M, Schubert D, Nadif Kasri N. The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective. Cell Mol Life Sci. 2021;78(6):2517–63.PubMedCrossRef

go back to reference Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006;125(2):315–26.PubMedCrossRef Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006;125(2):315–26.PubMedCrossRef

go back to reference Shah K, King GD, Jiang H. A chromatin modulator sustains self-renewal and enables differentiation of postnatal neural stem and progenitor cells. J Mol Cell Biol. 2020;12(1):4–16.PubMedCrossRef Shah K, King GD, Jiang H. A chromatin modulator sustains self-renewal and enables differentiation of postnatal neural stem and progenitor cells. J Mol Cell Biol. 2020;12(1):4–16.PubMedCrossRef

go back to reference Pereira JD, Sansom SN, Smith J, Dobenecker M, Tarakhovsky A, Livesey FJ, Crabtree GR. Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex. Proc Natl Acad Sci. 2010;107(36):15957–62.PubMedPubMedCentralCrossRef Pereira JD, Sansom SN, Smith J, Dobenecker M, Tarakhovsky A, Livesey FJ, Crabtree GR. Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex. Proc Natl Acad Sci. 2010;107(36):15957–62.PubMedPubMedCentralCrossRef

go back to reference Hwang WW, Salinas RD, Siu JJ, Kelley KW, Delgado RN, Paredes MF, Alvarez-Buylla A, Oldham MC, Lim DA. Distinct and separable roles for EZH2 in neurogenic astroglia. eLife. 2014;3:02439.CrossRef Hwang WW, Salinas RD, Siu JJ, Kelley KW, Delgado RN, Paredes MF, Alvarez-Buylla A, Oldham MC, Lim DA. Distinct and separable roles for EZH2 in neurogenic astroglia. eLife. 2014;3:02439.CrossRef

go back to reference Qiao Y, Wang R, Yang X, Tang K, Jing N. Dual roles of histone H3 lysine 9 acetylation in human embryonic stem cell pluripotency and neural differentiation. J Biol Chem. 2015;290(4):2508–20.PubMedCrossRef Qiao Y, Wang R, Yang X, Tang K, Jing N. Dual roles of histone H3 lysine 9 acetylation in human embryonic stem cell pluripotency and neural differentiation. J Biol Chem. 2015;290(4):2508–20.PubMedCrossRef

go back to reference Nothof SA, Magdinier F, Van-Gils J. Chromatin structure and dynamics: focus on neuronal differentiation and pathological implication. Genes (Basel). 2022;13(4):639. https://doi.org/10.3390/genes13040639.CrossRefPubMed Nothof SA, Magdinier F, Van-Gils J. Chromatin structure and dynamics: focus on neuronal differentiation and pathological implication. Genes (Basel). 2022;13(4):639. https://​doi.​org/​10.​3390/​genes13040639.CrossRefPubMed

go back to reference Fahrner JA, Bjornsson HT. Mendelian disorders of the epigenetic machinery: postnatal malleability and therapeutic prospects. Hum Mol Genet. 2019;28(R2):R254–64.PubMedPubMedCentralCrossRef Fahrner JA, Bjornsson HT. Mendelian disorders of the epigenetic machinery: postnatal malleability and therapeutic prospects. Hum Mol Genet. 2019;28(R2):R254–64.PubMedPubMedCentralCrossRef

go back to reference Biswas S, Rao CM. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy. Eur J Pharmacol. 2018;837:8–24.PubMedCrossRef Biswas S, Rao CM. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy. Eur J Pharmacol. 2018;837:8–24.PubMedCrossRef

go back to reference Yang AY, Kim H, Li W, Kong AT. Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers. Curr Top Med Chem. 2016;16(7):697–713.PubMedPubMedCentralCrossRef Yang AY, Kim H, Li W, Kong AT. Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers. Curr Top Med Chem. 2016;16(7):697–713.PubMedPubMedCentralCrossRef

go back to reference Giles KA, Gould CM, Du Q, Skvortsova K, Song JZ, Maddugoda MP, Achinger-Kawecka J, Stirzaker C, Clark SJ, Taberlay PC. Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups. Epigenetics Chromatin. 2019;12(1):12.PubMedPubMedCentralCrossRef Giles KA, Gould CM, Du Q, Skvortsova K, Song JZ, Maddugoda MP, Achinger-Kawecka J, Stirzaker C, Clark SJ, Taberlay PC. Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups. Epigenetics Chromatin. 2019;12(1):12.PubMedPubMedCentralCrossRef

go back to reference Boukas L, Havrilla JM, Hickey PF, Quinlan AR, Bjornsson HT, Hansen KD. Coexpression patterns define epigenetic regulators associated with neurological dysfunction. Genome Res. 2019;29(4):532–42.PubMedPubMedCentralCrossRef Boukas L, Havrilla JM, Hickey PF, Quinlan AR, Bjornsson HT, Hansen KD. Coexpression patterns define epigenetic regulators associated with neurological dysfunction. Genome Res. 2019;29(4):532–42.PubMedPubMedCentralCrossRef

go back to reference Lek M, Karczewski KJ, Minikel EV, Samocha KE, Posthuma D. Exome aggregation consortium [: analysis of protein-coding genetic variation in 60,706 humans. Nature (London). 2016;536(7616):285–91.PubMedCrossRef Lek M, Karczewski KJ, Minikel EV, Samocha KE, Posthuma D. Exome aggregation consortium [: analysis of protein-coding genetic variation in 60,706 humans. Nature (London). 2016;536(7616):285–91.PubMedCrossRef

go back to reference Bjornsson HT. The Mendelian disorders of the epigenetic machinery. Genome Res. 2015;25(10):1473–81.PubMedPubMedCentralCrossRef Bjornsson HT. The Mendelian disorders of the epigenetic machinery. Genome Res. 2015;25(10):1473–81.PubMedPubMedCentralCrossRef

go back to reference Jimenez-Sanchez G, Childs B, Valle D. Human disease genes. Nature. 2001;409(6822):853–5.PubMedCrossRef Jimenez-Sanchez G, Childs B, Valle D. Human disease genes. Nature. 2001;409(6822):853–5.PubMedCrossRef

go back to reference Larizza L, Finelli P. Developmental disorders with intellectual disability driven by chromatin dysregulation: clinical overlaps and molecular mechanisms. Clin Genet. 2019;95(2):231–40.PubMedCrossRef Larizza L, Finelli P. Developmental disorders with intellectual disability driven by chromatin dysregulation: clinical overlaps and molecular mechanisms. Clin Genet. 2019;95(2):231–40.PubMedCrossRef

go back to reference Luperchio TR, Boukas L, Zhang L, Pilarowski G, Jiang J, Kalinousky A, Hansen KD, Bjornsson HT. Leveraging the Mendelian disorders of the epigenetic machinery to systematically map functional epigenetic variation. Elife. 2021;10:e65884. https://doi.org/10.7554/eLife.65884.CrossRefPubMedPubMedCentral Luperchio TR, Boukas L, Zhang L, Pilarowski G, Jiang J, Kalinousky A, Hansen KD, Bjornsson HT. Leveraging the Mendelian disorders of the epigenetic machinery to systematically map functional epigenetic variation. Elife. 2021;10:e65884. https://​doi.​org/​10.​7554/​eLife.​65884.CrossRefPubMedPubMedCentral

go back to reference Tatton-Brown K, Seal S, Ruark E, Harmer J, Ramsay E, Del Vecchio Duarte S, Zachariou A, Hanks S, O’Brien E, Aksglaede L, Baralle D, Dabir T, Gener B, Goudie D, Homfray T, Kumar A, Pilz DT, Selicorni A, Temple IK, Van Maldergem L, Yachelevich N, van Montfort R, Rahman N. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat Genet. 2014;46(4):385–8.PubMedPubMedCentralCrossRef Tatton-Brown K, Seal S, Ruark E, Harmer J, Ramsay E, Del Vecchio Duarte S, Zachariou A, Hanks S, O’Brien E, Aksglaede L, Baralle D, Dabir T, Gener B, Goudie D, Homfray T, Kumar A, Pilz DT, Selicorni A, Temple IK, Van Maldergem L, Yachelevich N, van Montfort R, Rahman N. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat Genet. 2014;46(4):385–8.PubMedPubMedCentralCrossRef

go back to reference Tatton-Brown K, Zachariou A, Loveday C, Renwick A, Mahamdallie S, Aksglaede L, Baralle D, Barge-Schaapveld D, Blyth M, Bouma M, Breckpot J, Crabb B, Dabir T, Cormier-Daire V, Fauth C, Fisher R, Gener B, Goudie D, Homfray T, Hunter M, Jorgensen A, Kant SG, Kirally-Borri C, Koolen D, Kumar A, Labilloy A, Lees M, Marcelis C, Mercer C, Mignot C, Miller K, Neas K, Newbury-Ecob R, Pilz DT, Posmyk R, Prada C, Ramsey K, Randolph LM, Selicorni A, Shears D, Suri M, Temple IK, Turnpenny P, Val Maldergem L, Varghese V, Veenstra-Knol HE, Yachelevich N, Yates L, Rahman N. The Tatton-Brown-Rahman syndrome: a clinical study of 55 individuals with de novo constitutive DNMT3A variants. Wellcome Open Res. 2018;3:46.PubMedPubMedCentralCrossRef Tatton-Brown K, Zachariou A, Loveday C, Renwick A, Mahamdallie S, Aksglaede L, Baralle D, Barge-Schaapveld D, Blyth M, Bouma M, Breckpot J, Crabb B, Dabir T, Cormier-Daire V, Fauth C, Fisher R, Gener B, Goudie D, Homfray T, Hunter M, Jorgensen A, Kant SG, Kirally-Borri C, Koolen D, Kumar A, Labilloy A, Lees M, Marcelis C, Mercer C, Mignot C, Miller K, Neas K, Newbury-Ecob R, Pilz DT, Posmyk R, Prada C, Ramsey K, Randolph LM, Selicorni A, Shears D, Suri M, Temple IK, Turnpenny P, Val Maldergem L, Varghese V, Veenstra-Knol HE, Yachelevich N, Yates L, Rahman N. The Tatton-Brown-Rahman syndrome: a clinical study of 55 individuals with de novo constitutive DNMT3A variants. Wellcome Open Res. 2018;3:46.PubMedPubMedCentralCrossRef

go back to reference Lane C, Tatton-Brown K, Freeth M. Tatton-Brown-Rahman syndrome: cognitive and behavioural phenotypes. Dev Med Child Neurol. 2020;62(8):993–8.PubMedCrossRef Lane C, Tatton-Brown K, Freeth M. Tatton-Brown-Rahman syndrome: cognitive and behavioural phenotypes. Dev Med Child Neurol. 2020;62(8):993–8.PubMedCrossRef

go back to reference Tenorio J, Alarcón P, Arias P, Dapía I, García-Miñaur S, Palomares Bralo M, Campistol J, Climent S, Valenzuela I, Ramos S, Monseny AM, Grondona FL, Botet J, Serrano M, Solís M, Santos-Simarro F, Álvarez S, Teixidó-Tura G, Fernández Jaén A, Gordo G, Bardón Rivera MB, Nevado J, Hernández A, Cigudosa JC, Ruiz-Pérez VL, Tizzano EF, Lapunzina P. Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients. Eur J Human Genet. 2020;28(4):469–79.CrossRef Tenorio J, Alarcón P, Arias P, Dapía I, García-Miñaur S, Palomares Bralo M, Campistol J, Climent S, Valenzuela I, Ramos S, Monseny AM, Grondona FL, Botet J, Serrano M, Solís M, Santos-Simarro F, Álvarez S, Teixidó-Tura G, Fernández Jaén A, Gordo G, Bardón Rivera MB, Nevado J, Hernández A, Cigudosa JC, Ruiz-Pérez VL, Tizzano EF, Lapunzina P. Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients. Eur J Human Genet. 2020;28(4):469–79.CrossRef

go back to reference Balci TB, Strong A, Kalish JM, Zackai E, Maris JM, Reilly A, Surrey LF, Wertheim GB, Marcadier JL, Graham GE, Carter MT. Tatton-Brown-Rahman syndrome: six individuals with novel features. Am J Med Genet A. 2020;182(4):673–80.PubMedCrossRef Balci TB, Strong A, Kalish JM, Zackai E, Maris JM, Reilly A, Surrey LF, Wertheim GB, Marcadier JL, Graham GE, Carter MT. Tatton-Brown-Rahman syndrome: six individuals with novel features. Am J Med Genet A. 2020;182(4):673–80.PubMedCrossRef

go back to reference Christian DL, Wu DY, Martin JR, Moore JR, Liu YR, Clemens AW, Nettles SA, Kirkland NM, Papouin T, Hill CA, Wozniak DF, Dougherty JD, Gabel HW. DNMT3A haploinsufficiency results in behavioral deficits and global epigenomic dysregulation shared across neurodevelopmental disorders. Cell Rep (Cambridge). 2020;33(8):108416.CrossRef Christian DL, Wu DY, Martin JR, Moore JR, Liu YR, Clemens AW, Nettles SA, Kirkland NM, Papouin T, Hill CA, Wozniak DF, Dougherty JD, Gabel HW. DNMT3A haploinsufficiency results in behavioral deficits and global epigenomic dysregulation shared across neurodevelopmental disorders. Cell Rep (Cambridge). 2020;33(8):108416.CrossRef

go back to reference Beck DB, Petracovici A, He C, Moore HW, Louie RJ, Ansar M, Douzgou S, Sithambaram S, Cottrell T, Santos-Cortez RLP, Prijoles EJ, Bend R, Keren B, Mignot C, Nougues M, Õunap K, Reimand T, Pajusalu S, Zahid M, Saqib MAN, Buratti J, Seaby EG, McWalter K, Telegrafi A, Baldridge D, Shinawi M, Leal SM, Schaefer GB, Stevenson RE, Banka S, Bonasio R, Fahrner JA. Delineation of a human Mendelian disorder of the DNA demethylation machinery: TET3 deficiency. Am J Hum Genet. 2020;106(2):234–45.PubMedPubMedCentralCrossRef Beck DB, Petracovici A, He C, Moore HW, Louie RJ, Ansar M, Douzgou S, Sithambaram S, Cottrell T, Santos-Cortez RLP, Prijoles EJ, Bend R, Keren B, Mignot C, Nougues M, Õunap K, Reimand T, Pajusalu S, Zahid M, Saqib MAN, Buratti J, Seaby EG, McWalter K, Telegrafi A, Baldridge D, Shinawi M, Leal SM, Schaefer GB, Stevenson RE, Banka S, Bonasio R, Fahrner JA. Delineation of a human Mendelian disorder of the DNA demethylation machinery: TET3 deficiency. Am J Hum Genet. 2020;106(2):234–45.PubMedPubMedCentralCrossRef

go back to reference Antunes C, Da Silva JD, Guerra-Gomes S, Alves ND, Ferreira F, Loureiro-Campos E, Branco MR, Sousa N, Reik W, Pinto L, Marques CJ. Tet3 ablation in adult brain neurons increases anxiety-like behavior and regulates cognitive function in mice. Mol Psychiatry. 2021;26(5):1445–57.PubMedCrossRef Antunes C, Da Silva JD, Guerra-Gomes S, Alves ND, Ferreira F, Loureiro-Campos E, Branco MR, Sousa N, Reik W, Pinto L, Marques CJ. Tet3 ablation in adult brain neurons increases anxiety-like behavior and regulates cognitive function in mice. Mol Psychiatry. 2021;26(5):1445–57.PubMedCrossRef

go back to reference Antunes C, Da Silva JD, Guerra-Gomes S, Alves ND, Loureiro-Campos E, Pinto L, Marques CJ. Tet3 deletion in adult brain neurons of female mice results in anxiety-like behavior and cognitive impairments. Mol Neurobiol. 2022;59(8):4892–901.PubMedCrossRef Antunes C, Da Silva JD, Guerra-Gomes S, Alves ND, Loureiro-Campos E, Pinto L, Marques CJ. Tet3 deletion in adult brain neurons of female mice results in anxiety-like behavior and cognitive impairments. Mol Neurobiol. 2022;59(8):4892–901.PubMedCrossRef

go back to reference Fan B, Hao B, Dai Y, Xue L, Shi Y, Liu L, Xuan S, Yang N, Wang X, Zhao H. Deficiency of Tet3 in nucleus accumbens enhances fear generalization and anxiety-like behaviors in mice. Brain Pathol (Zurich, Switzerland). 2022;32(6):e13080-n/a.CrossRef Fan B, Hao B, Dai Y, Xue L, Shi Y, Liu L, Xuan S, Yang N, Wang X, Zhao H. Deficiency of Tet3 in nucleus accumbens enhances fear generalization and anxiety-like behaviors in mice. Brain Pathol (Zurich, Switzerland). 2022;32(6):e13080-n/a.CrossRef

go back to reference Kremer EA, Gaur N, Lee MA, Engmann O, Bohacek J, Mansuy IM. Interplay between TETs and microRNAs in the adult brain for memory formation. Sci Rep. 2018;8(1):1678–710.PubMedPubMedCentralCrossRef Kremer EA, Gaur N, Lee MA, Engmann O, Bohacek J, Mansuy IM. Interplay between TETs and microRNAs in the adult brain for memory formation. Sci Rep. 2018;8(1):1678–710.PubMedPubMedCentralCrossRef

go back to reference Janssen N, Bergman JEH, Swertz MA, Tranebjaerg L, Lodahl M, Schoots J, Hofstra RMW, van Ravenswaaij-Arts CMA, Hoefsloot LH. Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat. 2012;33(8):1149–60.PubMedCrossRef Janssen N, Bergman JEH, Swertz MA, Tranebjaerg L, Lodahl M, Schoots J, Hofstra RMW, van Ravenswaaij-Arts CMA, Hoefsloot LH. Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat. 2012;33(8):1149–60.PubMedCrossRef

go back to reference Vissers LELM, Ravenswaaij-Arts CMAv, Admiraal RJC, Hurst JA, Vries LBAd, Janssen IM, Vliet WAvd, Huys E, Jong PJd, Hamel BCJ, Schoenmakers EFPM, Brunner HG, Veltman JA, Geurts van Kessel A. H. M. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet. 2004;36(9):955–7.PubMedCrossRef Vissers LELM, Ravenswaaij-Arts CMAv, Admiraal RJC, Hurst JA, Vries LBAd, Janssen IM, Vliet WAvd, Huys E, Jong PJd, Hamel BCJ, Schoenmakers EFPM, Brunner HG, Veltman JA, Geurts van Kessel A. H. M. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet. 2004;36(9):955–7.PubMedCrossRef

go back to reference Pagon RA, Graham JM, Zonana J, Yong S. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr. 1981;99(2):223–7.PubMedCrossRef Pagon RA, Graham JM, Zonana J, Yong S. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr. 1981;99(2):223–7.PubMedCrossRef

go back to reference Lasserre E, Vaivre-Douret L, Abadie V. Psychomotor and cognitive impairments of children with CHARGE syndrome: common and variable features. Child Neuropsychol. 2013;19(5):449–65.PubMedCrossRef Lasserre E, Vaivre-Douret L, Abadie V. Psychomotor and cognitive impairments of children with CHARGE syndrome: common and variable features. Child Neuropsychol. 2013;19(5):449–65.PubMedCrossRef

go back to reference Vesseur A, Langereis M, Free R, Snik A, van Ravenswaaij-Arts C, Mylanus E. Influence of hearing loss and cognitive abilities on language development in CHARGE Syndrome. Am J Med Genet A. 2016;170(8):2022–30.PubMedCrossRef Vesseur A, Langereis M, Free R, Snik A, van Ravenswaaij-Arts C, Mylanus E. Influence of hearing loss and cognitive abilities on language development in CHARGE Syndrome. Am J Med Genet A. 2016;170(8):2022–30.PubMedCrossRef

go back to reference Raqbi F, Le Bihan C, Morisseau-Durand M, Dureau P, Lyonnet S, Abadie V. Early prognostic factors for intellectual outcome in CHARGE syndrome. Dev Med Child Neurol. 2003;45(7):483–8.PubMedCrossRef Raqbi F, Le Bihan C, Morisseau-Durand M, Dureau P, Lyonnet S, Abadie V. Early prognostic factors for intellectual outcome in CHARGE syndrome. Dev Med Child Neurol. 2003;45(7):483–8.PubMedCrossRef

go back to reference Wachtel LE, Hartshorne TS, Dailor AN. Psychiatric diagnoses and psychotropic medications in CHARGE syndrome: a pediatric survey. J Dev Phys Disabil. 2007;19(5):471–83.CrossRef Wachtel LE, Hartshorne TS, Dailor AN. Psychiatric diagnoses and psychotropic medications in CHARGE syndrome: a pediatric survey. J Dev Phys Disabil. 2007;19(5):471–83.CrossRef

go back to reference Blake KD, Salem-Hartshorne N, Daoud MA, Gradstein J. Adolescent and adult issues in charge syndrome. Clin Pediatr. 2005;44(2):151–9.CrossRef Blake KD, Salem-Hartshorne N, Daoud MA, Gradstein J. Adolescent and adult issues in charge syndrome. Clin Pediatr. 2005;44(2):151–9.CrossRef

go back to reference Hartshorne N, Hudson A, MacCuspie J, Kennert B, Nacarato T, Hartshorne T, Blake K. Quality of life in adolescents and adults with CHARGE syndrome. Am J Med Genet A. 2016;170A(8):2012–21.CrossRef Hartshorne N, Hudson A, MacCuspie J, Kennert B, Nacarato T, Hartshorne T, Blake K. Quality of life in adolescents and adults with CHARGE syndrome. Am J Med Genet A. 2016;170A(8):2012–21.CrossRef

go back to reference Hartshorne TS, Grialou TL, Parker KR. Autistic-like behavior in CHARGE syndrome. Am J Med Genet A. 2005;133A(3):257–61.PubMedCrossRef Hartshorne TS, Grialou TL, Parker KR. Autistic-like behavior in CHARGE syndrome. Am J Med Genet A. 2005;133A(3):257–61.PubMedCrossRef

go back to reference Souriau J, Gimenes M, Blouin C, Benbrik I, Benbrik E, Churakowskyi A, Churakowskyi B. CHARGE syndrome: developmental and behavioral data. Am J Med Genet A. 2005;133A(3):278–81.PubMedCrossRef Souriau J, Gimenes M, Blouin C, Benbrik I, Benbrik E, Churakowskyi A, Churakowskyi B. CHARGE syndrome: developmental and behavioral data. Am J Med Genet A. 2005;133A(3):278–81.PubMedCrossRef

go back to reference van Dijk JPM, de Kort A. Reducing challenging behaviors and fostering efficient learning of children with CHARGE syndrome. Am J Med Genet A. 2005;133A(3):273–7.PubMedCrossRef van Dijk JPM, de Kort A. Reducing challenging behaviors and fostering efficient learning of children with CHARGE syndrome. Am J Med Genet A. 2005;133A(3):273–7.PubMedCrossRef

go back to reference Thelin JW, Fussner JC. Factors related to the development of communication in CHARGE syndrome. Am J Med Genet A. 2005;133A(3):282–90.PubMedCrossRef Thelin JW, Fussner JC. Factors related to the development of communication in CHARGE syndrome. Am J Med Genet A. 2005;133A(3):282–90.PubMedCrossRef

go back to reference Graham JM Jr, Rosner B, Dykens E, Visootsak J. Behavioral features of CHARGE syndrome (Hall-Hittner syndrome) comparison with Down syndrome, Prader-Willi syndrome, and Williams syndrome. Am J Med Genet A. 2005;133A(3):240–7.PubMedCrossRef Graham JM Jr, Rosner B, Dykens E, Visootsak J. Behavioral features of CHARGE syndrome (Hall-Hittner syndrome) comparison with Down syndrome, Prader-Willi syndrome, and Williams syndrome. Am J Med Genet A. 2005;133A(3):240–7.PubMedCrossRef

go back to reference Fergelot P, Van Belzen M, Van Gils J, Afenjar A, Armour CM, Arveiler B, Beets L, Burglen L, Busa T, Collet M, Deforges J, de Vries BBA, Dominguez Garrido E, Dorison N, Dupont J, Francannet C, Garciá-Minaúr S, Gabau Vila E, Gebre-Medhin S, Gener Querol B, Geneviève D, Gérard M, Gervasini CG, Goldenberg A, Josifova D, Lachlan K, Maas S, Maranda B, Moilanen JS, Nordgren A, Parent P, Rankin J, Reardon W, Rio M, Roume J, Shaw A, Smigiel R, Sojo A, Solomon B, Stembalska A, Stumpel C, Suarez F, Terhal P, Thomas S, Touraine R, Verloes A, Vincent-Delorme C, Wincent J, Peters DJM, Bartsch O, Larizza L, Lacombe D, Hennekam RC. Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. Am J Med Genet A. 2016;170(12):3069–82.PubMedCrossRef Fergelot P, Van Belzen M, Van Gils J, Afenjar A, Armour CM, Arveiler B, Beets L, Burglen L, Busa T, Collet M, Deforges J, de Vries BBA, Dominguez Garrido E, Dorison N, Dupont J, Francannet C, Garciá-Minaúr S, Gabau Vila E, Gebre-Medhin S, Gener Querol B, Geneviève D, Gérard M, Gervasini CG, Goldenberg A, Josifova D, Lachlan K, Maas S, Maranda B, Moilanen JS, Nordgren A, Parent P, Rankin J, Reardon W, Rio M, Roume J, Shaw A, Smigiel R, Sojo A, Solomon B, Stembalska A, Stumpel C, Suarez F, Terhal P, Thomas S, Touraine R, Verloes A, Vincent-Delorme C, Wincent J, Peters DJM, Bartsch O, Larizza L, Lacombe D, Hennekam RC. Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. Am J Med Genet A. 2016;170(12):3069–82.PubMedCrossRef

go back to reference López M, García-Oguiza A, Armstrong J, García-Cobaleda I, García-Miñaur S, Santos-Simarro F, Seidel V, Domínguez-Garrido E. Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum. BMC Med Genet. 2018;19(1):36.PubMedPubMedCentralCrossRef López M, García-Oguiza A, Armstrong J, García-Cobaleda I, García-Miñaur S, Santos-Simarro F, Seidel V, Domínguez-Garrido E. Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum. BMC Med Genet. 2018;19(1):36.PubMedPubMedCentralCrossRef

go back to reference Adrien J, Taupiac E, Thiébaut E, Paulais M, Van-Gils J, Kaye K, Blanc R, Gattegno MP, Contejean Y, Michel G, Dean A, Barthélémy C, Lacombe D. A comparative study of cognitive and socio-emotional development in children with Rubinstein-Taybi syndrome and children with autism spectrum disorder associated with a severe intellectual disability, and in young typically developing children with matched developmental ages. Res Dev Disabil. 2021;116:104029.PubMedCrossRef Adrien J, Taupiac E, Thiébaut E, Paulais M, Van-Gils J, Kaye K, Blanc R, Gattegno MP, Contejean Y, Michel G, Dean A, Barthélémy C, Lacombe D. A comparative study of cognitive and socio-emotional development in children with Rubinstein-Taybi syndrome and children with autism spectrum disorder associated with a severe intellectual disability, and in young typically developing children with matched developmental ages. Res Dev Disabil. 2021;116:104029.PubMedCrossRef

go back to reference Galéra C, Taupiac E, Fraisse S, Naudion S, Toussaint E, Rooryck-Thambo C, Delrue M, Arveiler B, Lacombe D, Bouvard M. Socio-behavioral characteristics of children with Rubinstein-Taybi syndrome. J Autism Dev Disord. 2009;39(9):1252–60.PubMedCrossRef Galéra C, Taupiac E, Fraisse S, Naudion S, Toussaint E, Rooryck-Thambo C, Delrue M, Arveiler B, Lacombe D, Bouvard M. Socio-behavioral characteristics of children with Rubinstein-Taybi syndrome. J Autism Dev Disord. 2009;39(9):1252–60.PubMedCrossRef

go back to reference Taupiac E, Lacombe D, Thiébaut E, Van-Gils J, Michel G, Fergelot P, Adrien J. Psychomotor, cognitive, and socio-emotional developmental profiles of children with Rubinstein-Taybi syndrome and a severe intellectual disability. J Intellect Dev Disabil. 2021;46(1):80–9.CrossRef Taupiac E, Lacombe D, Thiébaut E, Van-Gils J, Michel G, Fergelot P, Adrien J. Psychomotor, cognitive, and socio-emotional developmental profiles of children with Rubinstein-Taybi syndrome and a severe intellectual disability. J Intellect Dev Disabil. 2021;46(1):80–9.CrossRef

go back to reference Waite J, Beck SR, Heald M, Powis L, Oliver C. Dissociation of cross-sectional trajectories for verbal and visuo-spatial working memory development in Rubinstein-Taybi syndrome. J Autism Dev Disord. 2016;46(6):2064–71.PubMedPubMedCentralCrossRef Waite J, Beck SR, Heald M, Powis L, Oliver C. Dissociation of cross-sectional trajectories for verbal and visuo-spatial working memory development in Rubinstein-Taybi syndrome. J Autism Dev Disord. 2016;46(6):2064–71.PubMedPubMedCentralCrossRef

go back to reference Ajmone PF, Avignone S, Gervasini C, Giacobbe A, Monti F, Costantino A, Esposito S, Marchisio P, Triulzi F, Milani D. Rubinstein-Taybi syndrome: new neuroradiological and neuropsychiatric insights from a multidisciplinary approach. Am J Med Genet Part B Neuropsychiatr Genet. 2018;177(4):406–15.CrossRef Ajmone PF, Avignone S, Gervasini C, Giacobbe A, Monti F, Costantino A, Esposito S, Marchisio P, Triulzi F, Milani D. Rubinstein-Taybi syndrome: new neuroradiological and neuropsychiatric insights from a multidisciplinary approach. Am J Med Genet Part B Neuropsychiatr Genet. 2018;177(4):406–15.CrossRef

go back to reference Crawford H, Waite J, Oliver C. Diverse profiles of anxiety related disorders in fragile X, Cornelia de Lange and Rubinstein-Taybi syndromes. J Autism Dev Disord. 2017;47(12):3728–40.PubMedPubMedCentralCrossRef Crawford H, Waite J, Oliver C. Diverse profiles of anxiety related disorders in fragile X, Cornelia de Lange and Rubinstein-Taybi syndromes. J Autism Dev Disord. 2017;47(12):3728–40.PubMedPubMedCentralCrossRef

go back to reference Awan N, Pearson E, Shelley L, Greenhill C, Tarver J, Waite J. The behavioral phenotype of Rubinstein-Taybi syndrome: a scoping review of the literature. Am J Med Genet A. 2022;188(9):2536–54.PubMedPubMedCentralCrossRef Awan N, Pearson E, Shelley L, Greenhill C, Tarver J, Waite J. The behavioral phenotype of Rubinstein-Taybi syndrome: a scoping review of the literature. Am J Med Genet A. 2022;188(9):2536–54.PubMedPubMedCentralCrossRef

go back to reference Kennedy J, Goudie D, Blair E, Chandler K, Joss S, McKay V, Green A, Armstrong R, Lees M, Kamien B, Hopper B, Tan TY, Yap P, Stark Z, Okamoto N, Miyake N, Matsumoto N, Macnamara E, Murphy JL, McCormick E, Hakonarson H, Falk MJ, Li D, Blackburn P, Klee E, Babovic-Vuksanovic D, Schelley S, Hudgins L, Kant S, Isidor B, Cogne B, Bradbury K, Williams M, Patel C, Heussler H, Duff-Farrier C, Lakeman P, Scurr I, Kini U, Elting M, Reijnders M, Schuurs-Hoeijmakers J, Wafik M, Blomhoff A, Ruivenkamp CAL, Nibbeling E, Dingemans AJM, Douine ED, Nelson SF, Arboleda VA, Newbury-Ecob R. KAT6A syndrome: genotype–phenotype correlation in 76 patients with pathogenic KAT6A variants. Genet Med. 2019;21(4):850–60.PubMedCrossRef Kennedy J, Goudie D, Blair E, Chandler K, Joss S, McKay V, Green A, Armstrong R, Lees M, Kamien B, Hopper B, Tan TY, Yap P, Stark Z, Okamoto N, Miyake N, Matsumoto N, Macnamara E, Murphy JL, McCormick E, Hakonarson H, Falk MJ, Li D, Blackburn P, Klee E, Babovic-Vuksanovic D, Schelley S, Hudgins L, Kant S, Isidor B, Cogne B, Bradbury K, Williams M, Patel C, Heussler H, Duff-Farrier C, Lakeman P, Scurr I, Kini U, Elting M, Reijnders M, Schuurs-Hoeijmakers J, Wafik M, Blomhoff A, Ruivenkamp CAL, Nibbeling E, Dingemans AJM, Douine ED, Nelson SF, Arboleda VA, Newbury-Ecob R. KAT6A syndrome: genotype–phenotype correlation in 76 patients with pathogenic KAT6A variants. Genet Med. 2019;21(4):850–60.PubMedCrossRef

go back to reference St John M, Amor DJ, Morgan AT. Speech and language development and genotype–phenotype correlation in 49 individuals with KAT6A syndrome. Am J Med Genet A. 2022;188(12):3389–400.PubMedCrossRef St John M, Amor DJ, Morgan AT. Speech and language development and genotype–phenotype correlation in 49 individuals with KAT6A syndrome. Am J Med Genet A. 2022;188(12):3389–400.PubMedCrossRef

go back to reference Smith C, Harris J. Sleep, behavior, and adaptive function in KAT6A syndrome. Brain Sci. 2021;11(8):966.PubMedPubMedCentralCrossRef Smith C, Harris J. Sleep, behavior, and adaptive function in KAT6A syndrome. Brain Sci. 2021;11(8):966.PubMedPubMedCentralCrossRef

go back to reference Boniel S, Szymańska K, Śmigiel R, Szczałuba K. Kabuki syndrome-clinical review with molecular aspects. Genes. 2021;12(4):468.PubMedPubMedCentralCrossRef Boniel S, Szymańska K, Śmigiel R, Szczałuba K. Kabuki syndrome-clinical review with molecular aspects. Genes. 2021;12(4):468.PubMedPubMedCentralCrossRef

go back to reference Jones W, Dafou D, McEntagart M, Woollard W, Elmslie F, Holder-Espinasse M, Irving M, Saggar A, Smithson S, Trembath R, Deshpande C, Simpson M. De novo mutations in MLL cause Wiedemann-Steiner syndrome. Am J Hum Genet. 2012;91(2):358–64.PubMedPubMedCentralCrossRef Jones W, Dafou D, McEntagart M, Woollard W, Elmslie F, Holder-Espinasse M, Irving M, Saggar A, Smithson S, Trembath R, Deshpande C, Simpson M. De novo mutations in MLL cause Wiedemann-Steiner syndrome. Am J Hum Genet. 2012;91(2):358–64.PubMedPubMedCentralCrossRef

go back to reference Bogershausen N, Wollnik B. Unmasking Kabuki syndrome. Clin Genet. 2013;83(3):201–11.PubMedCrossRef Bogershausen N, Wollnik B. Unmasking Kabuki syndrome. Clin Genet. 2013;83(3):201–11.PubMedCrossRef

go back to reference Niikawa N, Matsuura N, Fukushima Y, Ohsawa T, Kajii T. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr. 1981;99(4):565–9.PubMedCrossRef Niikawa N, Matsuura N, Fukushima Y, Ohsawa T, Kajii T. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr. 1981;99(4):565–9.PubMedCrossRef

go back to reference Lehman N, Mazery AC, Visier A, Baumann C, Lachesnais D, Capri Y, Toutain A, Odent S, Mikaty M, Goizet C, Taupiac E, Jacquemont ML, Sanchez E, Schaefer E, Gatinois V, Faivre L, Minot D, Kayirangwa H, Sang K-LQ, Boddaert N, Bayard S, Lacombe D, Moutton S, Touitou I, Rio M, Amiel J, Lyonnet S, Sanlaville D, Picot MC, Geneviève D. Molecular, clinical and neuropsychological study in 31 patients with Kabuki syndrome and KMT2D mutations. Clin Genet. 2017;92(3):298–305.PubMedCrossRef Lehman N, Mazery AC, Visier A, Baumann C, Lachesnais D, Capri Y, Toutain A, Odent S, Mikaty M, Goizet C, Taupiac E, Jacquemont ML, Sanchez E, Schaefer E, Gatinois V, Faivre L, Minot D, Kayirangwa H, Sang K-LQ, Boddaert N, Bayard S, Lacombe D, Moutton S, Touitou I, Rio M, Amiel J, Lyonnet S, Sanlaville D, Picot MC, Geneviève D. Molecular, clinical and neuropsychological study in 31 patients with Kabuki syndrome and KMT2D mutations. Clin Genet. 2017;92(3):298–305.PubMedCrossRef

go back to reference Sheppard SE, Campbell IM, Harr MH, Gold N, Li D, Bjornsson HT, Cohen JS, Fahrner JA, Fatemi A, Harris JR, Nowak C, Stevens CA, Grand K, Au M, Graham JM, Sanchez-Lara PA, Campo MD, Jones MC, Abdul-Rahman O, Bassetti JA, Bergstrom K, Bhoj E, Dugan S, Kaplan JD, Derar N, Gripp KW, Hauser N, Innes AM, Keena B, Kodra N, Miller R, Nelson B, Nowaczyk MJ, Rahbeeni Z, Ben-Shachar S, Shieh JT, Slavotinek A, Sobering AK, Abbott M, Allain DC, Amlie-Wolf L, Au PYB, Bedoukian E, Beek G, Barry J, Berg J, Bernstein JA, Cytrynbaum C, Chung BH, Donoghue S, Dorrani N, Eaton A, Flores-Daboub JA, Dubbs H, Felix CA, Fong C, Fung JLF, Gangaram B, Goldstein A, Greenberg R, Ha TK, Hersh J, Izumi K, Kravets E, Kwok P, Jobling RK, Knight Johnson AE, Kushner J, Lee BH, Levin B, Lindstrom K, Manickam K, Mardach R, McCormick E, McLeod DR, Mentch FD, Minks K, Muraresku C, Nelson SF, Porazzi P, Pichurin PN, Powell-Hamilton NN, Powis Z, Ritter A, Rogers C, Rohena L, Ronspies C, Schroeder A, Stark Z, Starr L, Stoler J, Suwannarat P, Velinov M, Weksberg R, Wilnai Y, Zadeh N, Falk MJ, Hakonarson H, Zackai EH, Quintero-Rivera F. Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner syndrome. Am J Med Genet A. 2021;185(6):1649–65.PubMedPubMedCentralCrossRef Sheppard SE, Campbell IM, Harr MH, Gold N, Li D, Bjornsson HT, Cohen JS, Fahrner JA, Fatemi A, Harris JR, Nowak C, Stevens CA, Grand K, Au M, Graham JM, Sanchez-Lara PA, Campo MD, Jones MC, Abdul-Rahman O, Bassetti JA, Bergstrom K, Bhoj E, Dugan S, Kaplan JD, Derar N, Gripp KW, Hauser N, Innes AM, Keena B, Kodra N, Miller R, Nelson B, Nowaczyk MJ, Rahbeeni Z, Ben-Shachar S, Shieh JT, Slavotinek A, Sobering AK, Abbott M, Allain DC, Amlie-Wolf L, Au PYB, Bedoukian E, Beek G, Barry J, Berg J, Bernstein JA, Cytrynbaum C, Chung BH, Donoghue S, Dorrani N, Eaton A, Flores-Daboub JA, Dubbs H, Felix CA, Fong C, Fung JLF, Gangaram B, Goldstein A, Greenberg R, Ha TK, Hersh J, Izumi K, Kravets E, Kwok P, Jobling RK, Knight Johnson AE, Kushner J, Lee BH, Levin B, Lindstrom K, Manickam K, Mardach R, McCormick E, McLeod DR, Mentch FD, Minks K, Muraresku C, Nelson SF, Porazzi P, Pichurin PN, Powell-Hamilton NN, Powis Z, Ritter A, Rogers C, Rohena L, Ronspies C, Schroeder A, Stark Z, Starr L, Stoler J, Suwannarat P, Velinov M, Weksberg R, Wilnai Y, Zadeh N, Falk MJ, Hakonarson H, Zackai EH, Quintero-Rivera F. Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner syndrome. Am J Med Genet A. 2021;185(6):1649–65.PubMedPubMedCentralCrossRef

go back to reference Baer S, Afenjar A, Smol T, Piton A, Gérard B, Alembik Y, Bienvenu T, Boursier G, Boute O, Colson C, Cordier M, Cormier-Daire V, Delobel B, Doco-Fenzy M, Duban-Bedu B, Fradin M, Geneviève D, Goldenberg A, Grelet M, Haye D, Heron D, Isidor B, Keren B, Lacombe D, Lèbre A, Lesca G, Masurel A, Mathieu-Dramard M, Nava C, Pasquier L, Petit A, Philip N, Piard J, Rondeau S, Saugier-Veber P, Sukno S, Thevenon J, Van-Gils J, Vincent-Delorme C, Willems M, Schaefer E, Morin G. Wiedemann-Steiner syndrome as a major cause of syndromic intellectual disability: a study of 33 French cases. Clin Genet. 2018;94(1):141–52.PubMedCrossRef Baer S, Afenjar A, Smol T, Piton A, Gérard B, Alembik Y, Bienvenu T, Boursier G, Boute O, Colson C, Cordier M, Cormier-Daire V, Delobel B, Doco-Fenzy M, Duban-Bedu B, Fradin M, Geneviève D, Goldenberg A, Grelet M, Haye D, Heron D, Isidor B, Keren B, Lacombe D, Lèbre A, Lesca G, Masurel A, Mathieu-Dramard M, Nava C, Pasquier L, Petit A, Philip N, Piard J, Rondeau S, Saugier-Veber P, Sukno S, Thevenon J, Van-Gils J, Vincent-Delorme C, Willems M, Schaefer E, Morin G. Wiedemann-Steiner syndrome as a major cause of syndromic intellectual disability: a study of 33 French cases. Clin Genet. 2018;94(1):141–52.PubMedCrossRef

go back to reference Harris J, Mahone EM, Bjornsson HT. Molecularly confirmed Kabuki (Niikawa-Kuroki) syndrome patients demonstrate a specific cognitive profile with extensive visuospatial abnormalities. J Intellect Disabil Res. 2019;63(6):489–97.PubMedPubMedCentralCrossRef Harris J, Mahone EM, Bjornsson HT. Molecularly confirmed Kabuki (Niikawa-Kuroki) syndrome patients demonstrate a specific cognitive profile with extensive visuospatial abnormalities. J Intellect Disabil Res. 2019;63(6):489–97.PubMedPubMedCentralCrossRef

go back to reference Ng R, Harris J, Fahrner JA, Bjornsson HT. Individuals with Wiedemann-Steiner syndrome show nonverbal reasoning and visuospatial defects with relative verbal skill sparing. J Int Neuropsychol Soc. 2022;29(5):1–7. Ng R, Harris J, Fahrner JA, Bjornsson HT. Individuals with Wiedemann-Steiner syndrome show nonverbal reasoning and visuospatial defects with relative verbal skill sparing. J Int Neuropsychol Soc. 2022;29(5):1–7.

go back to reference Dongen LCMv, Wingbermühle PAM, Veld WMvd, Stumpel CTRM, Kleefstra T, Egger JIM. Exploring the cognitive phenotype of Kabuki (NiikawaKuroki) syndrome. J Intellect Disabil Res. 2019;63(6):498–506.PubMedPubMedCentralCrossRef Dongen LCMv, Wingbermühle PAM, Veld WMvd, Stumpel CTRM, Kleefstra T, Egger JIM. Exploring the cognitive phenotype of Kabuki (NiikawaKuroki) syndrome. J Intellect Disabil Res. 2019;63(6):498–506.PubMedPubMedCentralCrossRef

go back to reference Mervis CB, Becerra AM, Rowe ML, Hersh JH, Morris CA. Intellectual abilities and adaptive behavior of children and adolescents with Kabuki syndrome: a preliminary study. Am J Med Genet A. 2005;132A(3):248–55.PubMedCrossRef Mervis CB, Becerra AM, Rowe ML, Hersh JH, Morris CA. Intellectual abilities and adaptive behavior of children and adolescents with Kabuki syndrome: a preliminary study. Am J Med Genet A. 2005;132A(3):248–55.PubMedCrossRef

go back to reference Kalinousky AJ, Rapp T, Hijazi H, Johnson J, Bjornsson HT, Harris JR. Neurobehavioral phenotype of Kabuki syndrome: anxiety is a common feature. Front Genet. 2022;13:1007046.PubMedPubMedCentralCrossRef Kalinousky AJ, Rapp T, Hijazi H, Johnson J, Bjornsson HT, Harris JR. Neurobehavioral phenotype of Kabuki syndrome: anxiety is a common feature. Front Genet. 2022;13:1007046.PubMedPubMedCentralCrossRef

go back to reference Theodore-Oklota C, Hartman DS, Hoffman DL, Björnsson HT. A qualitative study to characterize the humanistic burden of Kabuki syndrome in the United States and Canada. Adv Ther. 2021;39(1):619–31.PubMedPubMedCentralCrossRef Theodore-Oklota C, Hartman DS, Hoffman DL, Björnsson HT. A qualitative study to characterize the humanistic burden of Kabuki syndrome in the United States and Canada. Adv Ther. 2021;39(1):619–31.PubMedPubMedCentralCrossRef

go back to reference White SM, Thompson EM, Kidd A, Savarirayan R, Turner A, Amor D, Delatycki MB, Fahey M, Baxendale A, White S, Haan E, Gibson K, Halliday JL, Bankier A. Growth, behavior, and clinical findings in 27 patients with Kabuki (Niikawa-Kuroki) syndrome. Am J Med Genet A. 2004;127A(2):118–27.PubMedCrossRef White SM, Thompson EM, Kidd A, Savarirayan R, Turner A, Amor D, Delatycki MB, Fahey M, Baxendale A, White S, Haan E, Gibson K, Halliday JL, Bankier A. Growth, behavior, and clinical findings in 27 patients with Kabuki (Niikawa-Kuroki) syndrome. Am J Med Genet A. 2004;127A(2):118–27.PubMedCrossRef

go back to reference Morgan AT, Mei C, Da Costa A, Fifer J, Lederer D, Benoit V, McMillin MJ, Buckingham KJ, Bamshad MJ, Pope K, White SM. Speech and language in a genotyped cohort of individuals with Kabuki syndrome. Am J Med Genet A. 2015;167(7):1483–92.PubMedCrossRef Morgan AT, Mei C, Da Costa A, Fifer J, Lederer D, Benoit V, McMillin MJ, Buckingham KJ, Bamshad MJ, Pope K, White SM. Speech and language in a genotyped cohort of individuals with Kabuki syndrome. Am J Med Genet A. 2015;167(7):1483–92.PubMedCrossRef

go back to reference Durand B, Schaefer E, Burger P, Baer S, Schroder C, Mandel J, Piton A, Coutelle R. Neurocognitive and neurobehavioral characterization of two frequent forms of neurodevelopmental disorders: the DYRK1A and the Wiedemann-Steiner syndromes. Clin Genet. 2022;102(4):296–304.PubMedCrossRef Durand B, Schaefer E, Burger P, Baer S, Schroder C, Mandel J, Piton A, Coutelle R. Neurocognitive and neurobehavioral characterization of two frequent forms of neurodevelopmental disorders: the DYRK1A and the Wiedemann-Steiner syndromes. Clin Genet. 2022;102(4):296–304.PubMedCrossRef

go back to reference Ng R, Bjornsson HT, Fahrner JA, Harris J. Sleep disturbances correlate with behavioral problems among individuals with Wiedemann-Steiner syndrome. Front Genet. 2022;13:950082.PubMedPubMedCentralCrossRef Ng R, Bjornsson HT, Fahrner JA, Harris J. Sleep disturbances correlate with behavioral problems among individuals with Wiedemann-Steiner syndrome. Front Genet. 2022;13:950082.PubMedPubMedCentralCrossRef

go back to reference Ng R, Bjornsson HT, Fahrner JA, Harris J. Anxiety in wiedemann-steiner syndrome. Am J Med Genet A. 2022;191(2):437–44. Ng R, Bjornsson HT, Fahrner JA, Harris J. Anxiety in wiedemann-steiner syndrome. Am J Med Genet A. 2022;191(2):437–44.

go back to reference Chan AJS, Cytrynbaum C, Hoang N, Ambrozewicz PM, Weksberg R, Drmic I, Ritzema A, Schachar R, Walker S, Uddin M, Zarrei M, Yuen RKC, Scherer SW. Expanding the neurodevelopmental phenotypes of individuals with de novo KMT2A variants. NPJ Genom Med. 2019;4(1):9.PubMedPubMedCentralCrossRef Chan AJS, Cytrynbaum C, Hoang N, Ambrozewicz PM, Weksberg R, Drmic I, Ritzema A, Schachar R, Walker S, Uddin M, Zarrei M, Yuen RKC, Scherer SW. Expanding the neurodevelopmental phenotypes of individuals with de novo KMT2A variants. NPJ Genom Med. 2019;4(1):9.PubMedPubMedCentralCrossRef

go back to reference Ng R, Bjornsson HT, Fahrner JA, Harris J. High prosociality and social drive among individuals with Wiedemann-Steiner Syndrome. Minneapolis: American Academy of Clinical Neuropsychology Annual Conference; 2022. Ng R, Bjornsson HT, Fahrner JA, Harris J. High prosociality and social drive among individuals with Wiedemann-Steiner Syndrome. Minneapolis: American Academy of Clinical Neuropsychology Annual Conference; 2022.

go back to reference Aref-Eshghi E, Kerkhof J, Pedro VP, Groupe DI France, Barat-Houari M, Ruiz-Pallares N, Andrau J, Lacombe D, Van-Gils J, Fergelot P, Dubourg C, Cormier-Daire V, Rondeau S, Lecoquierre F, Saugier-Veber P, Nicolas G, Lesca G, Chatron N, Sanlaville D, Vitobello A, Faivre L, Thauvin-Robinet C, Laumonnier F, Raynaud M, Alders M, Mannens M, Henneman P, Hennekam RC, Velasco G, Francastel C, Ulveling D, Ciolfi A, Pizzi S, Tartaglia M, Heide S, Héron D, Mignot C, Keren B, Whalen S, Afenjar A, Bienvenu T, Campeau PM, Rousseau J, Levy MA, Brick L, Kozenko M, Balci TB, Siu VM, Stuart A, Kadour M, Masters J, Takano K, Kleefstra T, de Leeuw N, Field M, Shaw M, Gecz J, Ainsworth PJ, Lin H, Rodenhiser DI, Friez MJ, Tedder M, Lee JA, DuPont BR, Stevenson RE, Skinner SA, Schwartz CE, Genevieve D, Sadikovic B. Evaluation of DNA methylation episignatures for diagnosis and phenotype correlations in 42 Mendelian neurodevelopmental disorders. Am J Hum Genet. 2020;106(3):356–70.PubMedPubMedCentralCrossRef Aref-Eshghi E, Kerkhof J, Pedro VP, Groupe DI France, Barat-Houari M, Ruiz-Pallares N, Andrau J, Lacombe D, Van-Gils J, Fergelot P, Dubourg C, Cormier-Daire V, Rondeau S, Lecoquierre F, Saugier-Veber P, Nicolas G, Lesca G, Chatron N, Sanlaville D, Vitobello A, Faivre L, Thauvin-Robinet C, Laumonnier F, Raynaud M, Alders M, Mannens M, Henneman P, Hennekam RC, Velasco G, Francastel C, Ulveling D, Ciolfi A, Pizzi S, Tartaglia M, Heide S, Héron D, Mignot C, Keren B, Whalen S, Afenjar A, Bienvenu T, Campeau PM, Rousseau J, Levy MA, Brick L, Kozenko M, Balci TB, Siu VM, Stuart A, Kadour M, Masters J, Takano K, Kleefstra T, de Leeuw N, Field M, Shaw M, Gecz J, Ainsworth PJ, Lin H, Rodenhiser DI, Friez MJ, Tedder M, Lee JA, DuPont BR, Stevenson RE, Skinner SA, Schwartz CE, Genevieve D, Sadikovic B. Evaluation of DNA methylation episignatures for diagnosis and phenotype correlations in 42 Mendelian neurodevelopmental disorders. Am J Hum Genet. 2020;106(3):356–70.PubMedPubMedCentralCrossRef

go back to reference Montano C, Britton JF, Harris JR, Kerkhof J, Barnes BT, Lee JA, Sadikovic B, Sobreira N, Fahrner JA. Genome-wide DNA methylation profiling confirms a case of low-level mosaic Kabuki syndrome 1. Am J Med Genet Part A. 2022;188(7):2217–25.PubMedCrossRef Montano C, Britton JF, Harris JR, Kerkhof J, Barnes BT, Lee JA, Sadikovic B, Sobreira N, Fahrner JA. Genome-wide DNA methylation profiling confirms a case of low-level mosaic Kabuki syndrome 1. Am J Med Genet Part A. 2022;188(7):2217–25.PubMedCrossRef

go back to reference Levy MA, Relator R, McConkey H, Pranckeviciene E, Kerkhof J, Barat-Houari M, Bargiacchi S, Biamino E, Palomares Bralo M, Cappuccio G, Ciolfi A, Clarke A, DuPont BR, Elting MW, Faivre L, Fee T, Ferilli M, Fletcher RS, Cherick F, Foroutan A, Friez MJ, Gervasini C, Haghshenas S, Hilton BA, Jenkins Z, Kaur S, Lewis S, Louie RJ, Maitz S, Milani D, Morgan AT, Oegema R, Østergaard E, Pallares NR, Piccione M, Plomp AS, Poulton C, Reilly J, Rius R, Robertson S, Rooney K, Rousseau J, Santen GWE, Santos-Simarro F, Schijns J, Squeo GM, John MS, Thauvin-Robinet C, Traficante G, van der Sluijs PJ, Vergano SA, Vos N, Walden KK, Azmanov D, Balci TB, Banka S, Gecz J, Henneman P, Lee JA, Mannens MMAM, Roscioli T, Siu V, Amor DJ, Baynam G, Bend EG, Boycott K, Brunetti-Pierri N, Campeau PM, Campion D, Christodoulou J, Dyment D, Esber N, Fahrner JA, Fleming MD, Genevieve D, Heron D, Husson T, Kernohan KD, McNeill A, Menke LA, Merla G, Prontera P, Rockman-Greenberg C, Schwartz C, Skinner SA, Stevenson RE, Vincent M, Vitobello A, Tartaglia M, Alders M, Tedder ML, Sadikovic B. Functional correlation of genome-wide DNA methylation profiles in genetic neurodevelopmental disorders. Hum Mutat. 2022;43(11):1609–28.PubMedCrossRef Levy MA, Relator R, McConkey H, Pranckeviciene E, Kerkhof J, Barat-Houari M, Bargiacchi S, Biamino E, Palomares Bralo M, Cappuccio G, Ciolfi A, Clarke A, DuPont BR, Elting MW, Faivre L, Fee T, Ferilli M, Fletcher RS, Cherick F, Foroutan A, Friez MJ, Gervasini C, Haghshenas S, Hilton BA, Jenkins Z, Kaur S, Lewis S, Louie RJ, Maitz S, Milani D, Morgan AT, Oegema R, Østergaard E, Pallares NR, Piccione M, Plomp AS, Poulton C, Reilly J, Rius R, Robertson S, Rooney K, Rousseau J, Santen GWE, Santos-Simarro F, Schijns J, Squeo GM, John MS, Thauvin-Robinet C, Traficante G, van der Sluijs PJ, Vergano SA, Vos N, Walden KK, Azmanov D, Balci TB, Banka S, Gecz J, Henneman P, Lee JA, Mannens MMAM, Roscioli T, Siu V, Amor DJ, Baynam G, Bend EG, Boycott K, Brunetti-Pierri N, Campeau PM, Campion D, Christodoulou J, Dyment D, Esber N, Fahrner JA, Fleming MD, Genevieve D, Heron D, Husson T, Kernohan KD, McNeill A, Menke LA, Merla G, Prontera P, Rockman-Greenberg C, Schwartz C, Skinner SA, Stevenson RE, Vincent M, Vitobello A, Tartaglia M, Alders M, Tedder ML, Sadikovic B. Functional correlation of genome-wide DNA methylation profiles in genetic neurodevelopmental disorders. Hum Mutat. 2022;43(11):1609–28.PubMedCrossRef

go back to reference Conboy K, Henshall DC, Brennan GP. Epigenetic principles underlying epileptogenesis and epilepsy syndromes. Neurobiol Dis. 2021;148:105179.PubMedCrossRef Conboy K, Henshall DC, Brennan GP. Epigenetic principles underlying epileptogenesis and epilepsy syndromes. Neurobiol Dis. 2021;148:105179.PubMedCrossRef

go back to reference Rajarajan P, Jiang Y, Kassim BS, Akbarian S. Chromosomal conformations and epigenomic regulation in schizophrenia. Prog Mol Biol Transl Sci. 2018;157:21–40.PubMedPubMedCentralCrossRef Rajarajan P, Jiang Y, Kassim BS, Akbarian S. Chromosomal conformations and epigenomic regulation in schizophrenia. Prog Mol Biol Transl Sci. 2018;157:21–40.PubMedPubMedCentralCrossRef

go back to reference Siu MT, Weksberg R. Epigenetics of autism spectrum disorder. Adv Exp Med Biol. 2017;978:63–90.PubMedCrossRef Siu MT, Weksberg R. Epigenetics of autism spectrum disorder. Adv Exp Med Biol. 2017;978:63–90.PubMedCrossRef